Participant flow21

How many started, completed or left each group, period by period.

1 to 20 of 21

Period	Milestone	Group	Participants
Overall Study	STARTED	Placebo	136
Overall Study	STARTED	ESL 800 mg	135
Overall Study	STARTED	ESL 1200 mg	139
Overall Study	Randomized and Treated	Placebo	136
Overall Study	Randomized and Treated	ESL 800 mg	135
Overall Study	Randomized and Treated	ESL 1200 mg	139
Overall Study	Completed Tutration Period	Placebo	130
Overall Study	Completed Tutration Period	ESL 800 mg	134
Overall Study	Completed Tutration Period	ESL 1200 mg	131
Overall Study	Entered Maintenance Period	Placebo	129
Overall Study	Entered Maintenance Period	ESL 800 mg	133
Overall Study	Entered Maintenance Period	ESL 1200 mg	129
Overall Study	Completed Maintenance Period	Placebo	122
Overall Study	Completed Maintenance Period	ESL 800 mg	123
Overall Study	Completed Maintenance Period	ESL 1200 mg	110
Overall Study	COMPLETED	Placebo	122
Overall Study	COMPLETED	ESL 800 mg	122
Overall Study	COMPLETED	ESL 1200 mg	110
Overall Study	NOT COMPLETED	Placebo	14
Overall Study	NOT COMPLETED	ESL 800 mg	13

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01820559/flow